01 12ABX advanced biochemical compounds Biochemische Forschungsreagenzien GmbH
02 1Rotem Industries Ltd
01 1MANNOSE TRIFLATE
02 1Mannose Trflate plus, ultra pure
03 1Mannose Triflat, ultra pure
04 1Mannose Triflate Reference standard
05 1Mannose Triflate for Synthera Module
06 7Mannose Triflate, ultra pure
07 1Mannose triflate, ultra pure
01 1Israel
02 12U.S.A
.BETA.-D-MANNOPYRANOSE 1,3,4,6-TETRA-O-ACETATE 2-O-TRIFLUOROMETHANESULFONATE
NDC Package Code : 71934-0003
Start Marketing Date : 2016-01-04
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (500mg/500mg)
Marketing Category : BULK INGREDIENT
.BETA.-D-MANNOPYRANOSE 1,3,4,6-TETRA-O-ACETATE 2-O-TRIFLUOROMETHANESULFONATE
NDC Package Code : 71934-0004
Start Marketing Date : 2020-02-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (20mg/20mg)
Marketing Category : BULK INGREDIENT
.BETA.-D-MANNOPYRANOSE 1,3,4,6-TETRA-O-ACETATE 2-O-TRIFLUOROMETHANESULFONATE
NDC Package Code : 71934-0001
Start Marketing Date : 2001-10-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (40mg/40mg)
Marketing Category : BULK INGREDIENT
.BETA.-D-MANNOPYRANOSE 1,3,4,6-TETRA-O-ACETATE 2-O-TRIFLUOROMETHANESULFONATE
NDC Package Code : 71934-0005
Start Marketing Date : 2020-02-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25mg/25mg)
Marketing Category : BULK INGREDIENT
.BETA.-D-MANNOPYRANOSE 1,3,4,6-TETRA-O-ACETATE 2-O-TRIFLUOROMETHANESULFONATE
NDC Package Code : 71934-0008
Start Marketing Date : 2020-02-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25mg/25mg)
Marketing Category : BULK INGREDIENT
.BETA.-D-MANNOPYRANOSE 1,3,4,6-TETRA-O-ACETATE 2-O-TRIFLUOROMETHANESULFONATE
NDC Package Code : 71934-0006
Start Marketing Date : 2020-02-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (100mg/100mg)
Marketing Category : BULK INGREDIENT
.BETA.-D-MANNOPYRANOSE 1,3,4,6-TETRA-O-ACETATE 2-O-TRIFLUOROMETHANESULFONATE
NDC Package Code : 71934-0009
Start Marketing Date : 2020-02-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25mg/25mg)
Marketing Category : BULK INGREDIENT
.BETA.-D-MANNOPYRANOSE 1,3,4,6-TETRA-O-ACETATE 2-O-TRIFLUOROMETHANESULFONATE
NDC Package Code : 71934-0007
Start Marketing Date : 2020-02-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1000mg/1000mg)
Marketing Category : BULK INGREDIENT
.BETA.-D-MANNOPYRANOSE 1,3,4,6-TETRA-O-ACETATE 2-O-TRIFLUOROMETHANESULFONATE
NDC Package Code : 71934-0010
Start Marketing Date : 2020-02-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1000mg/1000mg)
Marketing Category : BULK INGREDIENT
.BETA.-D-MANNOPYRANOSE 1,3,4,6-TETRA-O-ACETATE 2-O-TRIFLUOROMETHANESULFONATE
NDC Package Code : 61704-001
Start Marketing Date : 2014-01-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1mg/mg)
Marketing Category : BULK INGREDIENT
25
PharmaCompass offers a list of TATM API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right TATM manufacturer or TATM supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred TATM manufacturer or TATM supplier.
PharmaCompass also assists you with knowing the TATM API Price utilized in the formulation of products. TATM API Price is not always fixed or binding as the TATM Price is obtained through a variety of data sources. The TATM Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A TATM manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of TATM, including repackagers and relabelers. The FDA regulates TATM manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. TATM API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A TATM supplier is an individual or a company that provides TATM active pharmaceutical ingredient (API) or TATM finished formulations upon request. The TATM suppliers may include TATM API manufacturers, exporters, distributors and traders.
click here to find a list of TATM suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing TATM as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for TATM API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture TATM as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain TATM and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a TATM NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of TATM suppliers with NDC on PharmaCompass.
We have 2 companies offering TATM
Get in contact with the supplier of your choice:
